0000849145 false Q3--12-31 0000849145 us-gaap:RestrictedStockMember hgbl:DavidLudwigAndTomLudwigMember 2018-06-01 2018-06-01 0000849145 us-gaap:TradeNamesMember hgbl:NLEXMember 2021-12-31 0000849145 2022-07-01 2022-09-30 0000849145 hgbl:HaywardFGHKIndustrialLLCMember 2021-12-31 0000849145 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000849145 hgbl:EdwardsvilleILMember hgbl:SeniorOfficerOfNLEXMember us-gaap:SellingGeneralAndAdministrativeExpensesMember hgbl:LeaseAmountsMember 2021-01-01 2021-09-30 0000849145 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000849145 us-gaap:TradeNamesMember hgbl:ALTMember 2021-12-31 0000849145 hgbl:CPFHLLCMember 2018-11-14 0000849145 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000849145 hgbl:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0000849145 us-gaap:CommercialAndIndustrialSectorMember 2021-01-01 2021-09-30 0000849145 hgbl:SanDiegoCaMember 2022-09-30 0000849145 us-gaap:CommonStockMember 2020-10-06 2020-10-06 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember hgbl:HGCFundingILLCMember 2022-01-01 2022-06-30 0000849145 us-gaap:CommonStockMember 2021-12-31 0000849145 us-gaap:CommonStockMember 2022-06-30 0000849145 2021-04-01 0000849145 hgbl:HGPTradeNamesMember 2022-01-01 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2021-03-31 0000849145 hgbl:KnfhLlcMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-12-31 0000849145 us-gaap:PreferredStockMember 2020-12-31 0000849145 us-gaap:CommonStockMember 2022-09-30 0000849145 hgbl:KnfhLlcMember 2022-04-30 0000849145 hgbl:KnfhLlcMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-09-30 0000849145 us-gaap:CorporateAndOtherMember 2022-07-01 2022-09-30 0000849145 us-gaap:IndefinitelivedIntangibleAssetsMember 2021-01-01 2021-09-30 0000849145 hgbl:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2022-09-30 0000849145 hgbl:DelMarCAMember 2021-12-31 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-01-01 2021-09-30 0000849145 hgbl:DelMarCAMember 2022-09-30 0000849145 us-gaap:ServiceMember 2022-01-01 2022-09-30 0000849145 hgbl:CPFHLLCMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-01-01 2022-09-30 0000849145 hgbl:NLEXMember 2022-09-30 0000849145 us-gaap:AccountingStandardsUpdate201409Member 2022-09-30 0000849145 srt:MaximumMember hgbl:CThreeBankNationalAssociationMember 2021-05-05 2021-05-05 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-01-01 2021-06-30 0000849145 us-gaap:CorporateAndOtherMember 2021-07-01 2021-09-30 0000849145 2022-09-01 0000849145 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000849145 hgbl:TwoThousandAndSixteenStockOptionPlanMember 2022-01-01 2022-09-30 0000849145 hgbl:UnrestrictedMember 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000849145 2022-01-01 2022-03-31 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-12-31 0000849145 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0000849145 hgbl:EdwardsvilleILMember hgbl:SeniorOfficerOfNLEXMember hgbl:LeaseAmountsMember 2018-06-01 2018-06-01 0000849145 2021-03-31 0000849145 us-gaap:CustomerRelationshipsMember hgbl:HGPMember 2021-12-31 0000849145 us-gaap:PrimeRateMember us-gaap:SubsidiaryOfCommonParentMember 2021-05-05 2021-05-05 0000849145 2019-06-30 0000849145 hgbl:ALTMember us-gaap:TradeNamesMember 2022-01-01 2022-09-30 0000849145 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000849145 us-gaap:PreferredStockMember 2021-03-31 0000849145 us-gaap:ServiceMember 2021-01-01 2021-09-30 0000849145 2021-01-01 2021-09-30 0000849145 us-gaap:CustomerRelationshipsMember 2022-09-30 0000849145 us-gaap:CommercialAndIndustrialSectorMember 2021-07-01 2021-09-30 0000849145 us-gaap:RestrictedStockMember 2022-09-30 0000849145 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000849145 hgbl:CommonStockOptionMember 2022-01-01 2022-09-30 0000849145 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000849145 hgbl:KnfhLlcMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-01-01 2022-06-30 0000849145 us-gaap:TreasuryStockMember 2021-12-31 0000849145 hgbl:VendorRelationshipsMember hgbl:ALTMember 2021-12-31 0000849145 us-gaap:TreasuryStockMember 2022-04-01 2022-06-30 0000849145 us-gaap:PreferredStockMember 2021-06-30 0000849145 hgbl:HaywardFGHKIndustrialLLCMember srt:MaximumMember 2020-10-27 2020-10-27 0000849145 hgbl:ALTMember hgbl:VendorRelationshipsMember 2022-01-01 2022-09-30 0000849145 hgbl:DavidLudwigAndTomLudwigMember 2018-06-01 2018-06-01 0000849145 2022-01-01 2022-09-30 0000849145 hgbl:SanDiegoCaMember 2021-12-31 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember hgbl:HGCFundingILLCMember 2021-01-01 2021-09-30 0000849145 hgbl:HaywardFGHKIndustrialLLCMember 2020-10-27 2020-10-27 0000849145 us-gaap:PreferredStockMember 2021-09-30 0000849145 hgbl:NonEmployeeDirectorsMember 2022-01-01 2022-09-30 0000849145 hgbl:KnfhLlcMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-01-01 2021-09-30 0000849145 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000849145 us-gaap:RetainedEarningsMember 2020-12-31 0000849145 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000849145 us-gaap:RetainedEarningsMember 2022-03-31 0000849145 2020-12-31 0000849145 us-gaap:TradeNamesMember hgbl:ALTMember 2022-09-30 0000849145 us-gaap:RealEstateMember 2022-03-31 0000849145 srt:MaximumMember hgbl:LibertyIndustrialParkLlcMember 2022-08-12 2022-08-12 0000849145 hgbl:EdwardsvilleILMember 2022-09-30 0000849145 hgbl:CPFHLLCMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-01-01 2022-06-30 0000849145 hgbl:EdwardsvilleILMember 2021-12-31 0000849145 us-gaap:ProductMember 2022-07-01 2022-09-30 0000849145 us-gaap:CorporateAndOtherMember 2021-01-01 2021-09-30 0000849145 us-gaap:CommonStockMember 2020-12-31 0000849145 us-gaap:CustomerRelationshipsMember hgbl:HGPMember 2022-01-01 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2021-12-31 0000849145 2022-04-01 2022-06-30 0000849145 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000849145 us-gaap:CommonStockMember 2021-03-31 0000849145 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-09-30 0000849145 us-gaap:CommonStockMember 2022-03-31 0000849145 us-gaap:MachineryAndEquipmentMember 2019-06-30 0000849145 hgbl:CPFHLLCMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-12-31 0000849145 hgbl:HGPMember 2021-12-31 0000849145 hgbl:EdwardsvilleILMember hgbl:SeniorOfficerOfNLEXMember us-gaap:SellingGeneralAndAdministrativeExpensesMember hgbl:LeaseAmountsMember 2022-01-01 2022-09-30 0000849145 us-gaap:ServiceMember 2021-07-01 2021-09-30 0000849145 2019-01-01 0000849145 2020-10-27 0000849145 hgbl:CommonStockOptionMember 2022-09-30 0000849145 us-gaap:FinancialServicesSectorMember 2022-07-01 2022-09-30 0000849145 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000849145 2021-06-30 0000849145 2022-06-30 0000849145 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000849145 us-gaap:RestrictedStockMember hgbl:DavidLudwigAndTomLudwigMember 2022-01-01 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2021-06-30 0000849145 hgbl:CThreeBankNationalAssociationMember 2021-05-05 2021-05-05 0000849145 hgbl:HGPTradeNamesMember 2021-12-31 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-01-01 2022-09-30 0000849145 hgbl:CThreeBankNationalAssociationMember 2021-05-05 0000849145 us-gaap:PreferredStockMember 2022-03-31 0000849145 us-gaap:AccountingStandardsUpdate201409Member 2022-01-01 2022-09-30 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-01-01 2022-06-30 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember hgbl:HGCFundingILLCMember 2022-01-01 2022-09-30 0000849145 hgbl:KnfhLlcMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-01-01 2021-06-30 0000849145 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000849145 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000849145 hgbl:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2022-08-03 2022-08-03 0000849145 hgbl:ALTMember hgbl:VendorRelationshipsMember 2022-09-30 0000849145 hgbl:EmployeesMember 2022-01-01 2022-09-30 0000849145 2022-03-31 0000849145 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0000849145 hgbl:HaywardFGHKIndustrialLLCMember 2020-10-27 0000849145 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000849145 us-gaap:RetainedEarningsMember 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2021-09-30 0000849145 hgbl:CPFHLLCMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-09-30 0000849145 us-gaap:CommonStockMember 2021-06-30 0000849145 hgbl:NonExecutiveDirectorsMember 2022-08-03 2022-08-03 0000849145 2021-04-01 2021-06-30 0000849145 2021-07-01 2021-09-30 0000849145 us-gaap:ProductMember 2022-01-01 2022-09-30 0000849145 us-gaap:TreasuryStockMember 2022-03-31 0000849145 us-gaap:SubsidiaryOfCommonParentMember 2021-08-23 2021-08-23 0000849145 us-gaap:CommercialAndIndustrialSectorMember 2022-07-01 2022-09-30 0000849145 us-gaap:CommonStockMember 2021-09-30 0000849145 us-gaap:FinancialServicesSectorMember 2022-01-01 2022-09-30 0000849145 us-gaap:CorporateAndOtherMember 2022-01-01 2022-09-30 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-09-30 0000849145 us-gaap:PreferredStockMember 2022-06-30 0000849145 hgbl:KnfhLlcMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-01-01 2022-09-30 0000849145 2021-12-31 0000849145 hgbl:ALTMember 2021-12-31 0000849145 us-gaap:CommercialAndIndustrialSectorMember 2022-01-01 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2022-06-30 0000849145 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0000849145 hgbl:CPFHLLCMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-01-01 2021-09-30 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember hgbl:HGCFundingILLCMember 2022-09-30 0000849145 2021-09-30 0000849145 hgbl:LibertyIndustrialParkLlcMember 2022-08-12 2022-08-12 0000849145 hgbl:OakGroveAssetAcquisitionsLPMember 2022-01-01 2022-09-30 0000849145 hgbl:ALTMember 2022-09-30 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember hgbl:HGCFundingILLCMember 2021-12-31 0000849145 us-gaap:ProductMember 2021-01-01 2021-09-30 0000849145 us-gaap:PreferredStockMember 2021-12-31 0000849145 hgbl:LibertyIndustrialParkLlcMember 2022-08-12 0000849145 us-gaap:TreasuryStockMember 2022-06-30 0000849145 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000849145 us-gaap:SubsidiaryOfCommonParentMember 2022-01-01 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000849145 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000849145 hgbl:EquityIncentivePlanMember 2022-09-30 0000849145 hgbl:RestrictedMember 2022-09-30 0000849145 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember hgbl:HGCFundingILLCMember 2021-01-01 2021-06-30 0000849145 us-gaap:RestrictedStockMember hgbl:ScottWestMember 2021-03-29 2021-03-30 0000849145 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000849145 hgbl:CPFHLLCMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-01-01 2021-06-30 0000849145 us-gaap:FinancialServicesSectorMember 2021-01-01 2021-09-30 0000849145 2022-11-01 0000849145 hgbl:HGPMember 2022-09-30 0000849145 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000849145 us-gaap:RestrictedStockMember hgbl:ScottWestMember 2021-03-30 2021-03-30 0000849145 2021-01-01 2021-03-31 0000849145 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000849145 us-gaap:ServiceMember 2022-07-01 2022-09-30 0000849145 hgbl:HaywardFGHKIndustrialLLCMember 2022-09-30 0000849145 2022-01-01 2022-06-30 0000849145 hgbl:HGPTradeNamesMember 2022-09-30 0000849145 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember hgbl:CThreeBankNationalAssociationMember 2022-08-23 2022-08-23 0000849145 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000849145 hgbl:NLEXMember 2021-12-31 0000849145 us-gaap:TreasuryStockMember 2022-09-30 0000849145 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000849145 us-gaap:TradeNamesMember hgbl:NLEXMember 2022-09-30 0000849145 us-gaap:SubsidiaryOfCommonParentMember 2021-08-23 0000849145 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000849145 us-gaap:MachineryAndEquipmentMember 2019-06-01 2019-06-30 0000849145 srt:MaximumMember us-gaap:AccountingStandardsUpdate201409Member 2022-07-01 2022-09-30 0000849145 hgbl:OakGroveAssetAcquisitionsLPMember 2021-01-01 2021-09-30 0000849145 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000849145 us-gaap:ProductMember 2021-07-01 2021-09-30 0000849145 us-gaap:RealEstateMember 2019-06-30 0000849145 us-gaap:CustomerRelationshipsMember hgbl:HGPMember 2022-09-30 0000849145 us-gaap:PreferredStockMember 2022-09-30 0000849145 us-gaap:FinancialServicesSectorMember 2021-07-01 2021-09-30 0000849145 2019-06-01 2019-06-30 xbrli:pure utr:sqft xbrli:shares hgbl:Segment iso4217:USD xbrli:shares hgbl:Location iso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-39471

HERITAGE GLOBAL INC.

(Exact name of registrant as specified in its charter)

Florida | 59-2291344
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.)

12625 High Bluff Drive, Suite 305, San Diego, CA 92130

(Address of Principal Executive Offices)

(858) 847-0659
(Registrant’s Telephone Number)

N/A

(Registrant’s Former Name)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common stock, $0.01 par value | HGBL | The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer | ☐ |  | Accelerated Filer | ☐
Non-Accelerated Filer | ☒ |  | Smaller reporting company | ☒
|  |  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 1, 2022, there were 36,932,177 s hares of common stock, $0.01 par value, outstanding.

TABLE OF CONTENTS

Part I. | Financial Information | 3
Item 1. | Financial Statements | 3
| Condensed Consolidated Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021 | 3
| Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2022 and 2021 (unaudited) | 4
| Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2022 and 2021 (unaudited) | 5
| Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 (unaudited) | 6
| Notes to Condensed Consolidated Financial Statements | 7
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 18
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 27
Item 4. | Controls and Procedures | 27
Part II. | Other Information | 28
Item 1. | Legal Proceedings | 28
Item 1A. | Risk Factors | 28
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 28
Item 3. | Defaults Upon Senior Securities | 28
Item 4. | Mine Safety Disclosures | 28
Item 5. | Other Information | 29
Item 6. | Exhibits | 29

2

PART I – FINANC I AL INFORMATION

Item 1 – Financ ial Statements.

HERITAGE GLOBAL INC.

CONDENSED CONSOLIDA TED BALANCE SHEETS

(In thousands of US dollars, except share and per share amounts) (unaudited)

|  | September 30, 2022 |  |  | December 31, 2021 |
ASSETS |  |  |  |  |  |
Current assets: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 17,482 |  |  | $ | 13,622 |
Accounts receivable (net of allowance for doubtful accounts of $122 in 2022 and 2021) |  |  | 1,670 |  |  |  | 2,732 |
Current portion of notes receivable, net |  |  | 1,341 |  |  |  | 2,254 |
Inventory – equipment |  |  | 4,822 |  |  |  | 3,220 |
Other current assets |  |  | 1,160 |  |  |  | 1,456 |
Total current assets |  |  | 26,475 |  |  |  | 23,284 |
Non-current portion of notes receivable, net |  |  | 751 |  |  |  | 1,784 |
Equity method investments |  |  | 8,499 |  |  |  | 4,683 |
Right-of-use assets |  |  | 2,933 |  |  |  | 2,694 |
Property and equipment, net |  |  | 1,481 |  |  |  | 1,471 |
Intangible assets, net |  |  | 4,250 |  |  |  | 4,565 |
Goodwill |  |  | 7,446 |  |  |  | 7,446 |
Deferred tax assets |  |  | 3,117 |  |  |  | 4,488 |
Other assets |  |  | 64 |  |  |  | 49 |
Total assets |  | $ | 55,016 |  |  | $ | 50,464 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |
Accounts payable and accrued liabilities |  | $ | 6,323 |  |  | $ | 4,793 |
Payables to sellers |  |  | 5,890 |  |  |  | 6,451 |
Current portion of third party debt |  |  | 531 |  |  |  | 2,479 |
Current portion of lease liabilities |  |  | 714 |  |  |  | 501 |
Total current liabilities |  |  | 13,458 |  |  |  | 14,224 |
Non-current portion of third party debt |  |  | 993 |  |  |  | 1,352 |
Non-current portion of lease liabilities |  |  | 2,293 |  |  |  | 2,249 |
Total liabilities |  |  | 16,744 |  |  |  | 17,825 |
Stockholders’ equity: |  |  |  |  |  |
Preferred stock, $10.00 par value, authorized 10,000,000 shares; issued and outstanding 565 shares of Series N as of September 30, 2022 and December 31, 2021 |  |  | 6 |  |  |  | 6 |
Common stock, $0.01 par value, authorized 300,000,000 shares; issued and outstanding 36,932,177 shares as of September 30, 2022 and 36,574,702 shares as of December 31, 2021 |  |  | 369 |  |  |  | 366 |
Additional paid-in capital |  |  | 293,433 |  |  |  | 293,030 |
Treasury stock at cost, 183,699 shares as of September 30, 2022 and 0 shares as of December 31, 2021 |  |  | (296 | ) |  |  | — |
Accumulated deficit |  |  | (255,240 | ) |  |  | (260,763 | )
Total stockholders’ equity |  |  | 38,272 |  |  |  | 32,639 |
Total liabilities and stockholders’ equity |  | $ | 55,016 |  |  | $ | 50,464 |

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

HERITAGE GLOBAL INC.

CONDENSED CONSOLIDATED S TATEMENTS OF INCOME

(In thousands of US dollars, except share and per share amounts)

(unaudited)

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Revenues: |  |  |  |  |  |  |  |  |  |  |  |
Services revenue |  | $ | 7,349 |  |  | $ | 4,822 |  |  | $ | 16,112 |  |  | $ | 14,020 |
Asset sales |  |  | 5,312 |  |  |  | 1,169 |  |  |  | 16,971 |  |  |  | 4,248 |
Total revenues |  |  | 12,661 |  |  |  | 5,991 |  |  |  | 33,083 |  |  |  | 18,268 |
Operating costs and expenses: |  |  |  |  |  |  |  |  |  |  |  |
Cost of services revenue |  |  | 2,051 |  |  |  | 1,100 |  |  |  | 3,715 |  |  |  | 3,235 |
Cost of asset sales |  |  | 3,015 |  |  |  | 675 |  |  |  | 12,048 |  |  |  | 1,870 |
Selling, general and administrative |  |  | 5,693 |  |  |  | 3,494 |  |  |  | 14,907 |  |  |  | 11,134 |
Depreciation and amortization |  |  | 134 |  |  |  | 105 |  |  |  | 400 |  |  |  | 294 |
Total operating costs and expenses |  |  | 10,893 |  |  |  | 5,374 |  |  |  | 31,070 |  |  |  | 16,533 |
Earnings of equity method investments |  |  | 1,706 |  |  |  | (84 | ) |  |  | 5,960 |  |  |  | (83 | )
Operating income |  |  | 3,474 |  |  |  | 533 |  |  |  | 7,973 |  |  |  | 1,652 |
Interest and other expense, net |  |  | (21 | ) |  |  | (6 | ) |  |  | (96 | ) |  |  | 6 |
Income before income tax expense (benefit) |  |  | 3,453 |  |  |  | 527 |  |  |  | 7,877 |  |  |  | 1,658 |
Income tax expense (benefit) |  |  | 1,153 |  |  |  | 53 |  |  |  | 2,354 |  |  |  | (435 | )
Net income |  | $ | 2,300 |  |  | $ | 474 |  |  | $ | 5,523 |  |  | $ | 2,093 |
Weighted average common shares outstanding – basic |  |  | 36,084,696 |  |  |  | 35,805,227 |  |  |  | 36,014,439 |  |  |  | 35,285,128 |
Weighted average common shares outstanding – diluted |  |  | 37,221,430 |  |  |  | 37,090,294 |  |  |  | 36,872,977 |  |  |  | 36,567,713 |
Net income per share – basic |  | $ | 0.06 |  |  | $ | 0.01 |  |  | $ | 0.15 |  |  | $ | 0.06 |
Net income per share – diluted |  | $ | 0.06 |  |  | $ | 0.01 |  |  | $ | 0.15 |  |  | $ | 0.06 |

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

HERITAGE GLOBAL INC.

CONDENSED CONSOLIDATED STATEM ENTS OF STOCKHOLDERS’ EQUITY

(In thousands of US dollars, except share amounts)
(unaudited)

|  |  |  |  |  |  |  |  |  |  | Additional |  |  |  |  |  |  |  |  |  |
|  | Preferred stock |  |  | Common stock |  |  | paid-in |  |  | Treasury stock |  |  | Accumulated |  |  |  |
|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | capital |  |  | Shares |  |  | Amount |  |  | deficit |  |  | Total |
Balance as of December 31, 2021 |  |  | 565 |  |  | $ | 6 |  |  |  | 36,574,702 |  |  | $ | 366 |  |  | $ | 293,030 |  |  |  | — |  |  | $ | — |  |  | $ | (260,763 | ) |  | $ | 32,639 |
Issuance of common stock from stock option awards |  |  | — |  |  |  | — |  |  |  | 103,135 |  |  |  | 1 |  |  |  | (24 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (23 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 106 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 106 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 645 |  |  |  | 645 |
Balance as of March 31, 2022 |  |  | 565 |  |  |  | 6 |  |  |  | 36,677,837 |  |  |  | 367 |  |  |  | 293,112 |  |  |  | — |  |  |  | — |  |  |  | (260,118 | ) |  |  | 33,367 |
Issuance of common stock from stock option awards |  |  | — |  |  |  | — |  |  |  | 56,250 |  |  |  | — |  |  |  | 25 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 25 |
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 108 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 108 |
Repurchase of common stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 71,512 |  |  |  | (105 | ) |  |  | — |  |  |  | (105 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2,578 |  |  |  | 2,578 |
Balance as of June 30, 2022 |  |  | 565 |  |  |  | 6 |  |  |  | 36,734,087 |  |  |  | 367 |  |  |  | 293,245 |  |  |  | 71,512 |  |  |  | (105 | ) |  |  | (257,540 | ) |  |  | 35,973 |
Issuance of common stock from stock option awards |  |  | — |  |  |  | — |  |  |  | 83,090 |  |  |  | 1 |  |  |  | 19 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 20 |
Issuance of restricted common stock |  |  | — |  |  |  | — |  |  |  | 115,000 |  |  |  | 1 |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 170 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 170 |
Repurchase of common stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 112,187 |  |  |  | (191 | ) |  |  | — |  |  |  | (191 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2,300 |  |  |  | 2,300 |
Balance as of September 30, 2022 |  |  | 565 |  |  | $ | 6 |  |  |  | 36,932,177 |  |  | $ | 369 |  |  | $ | 293,433 |  |  |  | 183,699 |  |  | $ | (296 | ) |  | $ | (255,240 | ) |  | $ | 38,272 |

|  |  |  |  |  |  |  |  |  |  | Additional |  |  |  |  |  |  |  |  |  |
|  | Preferred stock |  |  | Common stock |  |  | paid-in |  |  | Treasury stock |  |  | Accumulated |  |  |  |
|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | capital |  |  | Shares |  |  | Amount |  |  | deficit |  |  | Total |
Balance as of December 31, 2020 |  |  | 568 |  |  | $ | 6 |  |  |  | 35,281,183 |  |  | $ | 353 |  |  | $ | 293,400 |  |  |  | — |  |  | $ | — |  |  | $ | (263,816 | ) |  | $ | 29,943 |
Issuance of common stock from stock option awards |  |  | — |  |  |  | — |  |  |  | 366,294 |  |  |  | 4 |  |  |  | (124 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (120 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 67 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 67 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,032 |  |  |  | 1,032 |
Balance as of March 31, 2021 |  |  | 568 |  |  |  | 6 |  |  |  | 35,647,477 |  |  |  | 357 |  |  |  | 293,343 |  |  |  | — |  |  |  | — |  |  |  | (262,784 | ) |  |  | 30,922 |
Issuance of common stock from stock option awards |  |  | — |  |  |  | — |  |  |  | 611,905 |  |  |  | 6 |  |  |  | (676 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (670 | )
Issuance of restricted common stock |  |  | — |  |  |  | — |  |  |  | 25,000 |  |  |  | — |  |  |  | 76 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 76 |
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 68 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 68 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 587 |  |  |  | 587 |
Balance as of June 30, 2021 |  |  | 568 |  |  |  | 6 |  |  |  | 36,284,382 |  |  |  | 363 |  |  |  | 292,811 |  |  |  | — |  |  |  | — |  |  |  | (262,197 | ) |  |  | 30,983 |
Issuance of common stock from stock option awards |  |  | — |  |  |  | — |  |  |  | 290,200 |  |  |  | 3 |  |  |  | 22 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 25 |
Issuance of common stock due to conversion of Series N Preferred stock |  |  | (3 | ) |  |  | — |  |  |  | 120 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 102 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 102 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 474 |  |  |  | 474 |
Balance as of September 30, 2021 |  |  | 565 |  |  | $ | 6 |  |  |  | 36,574,702 |  |  | $ | 366 |  |  | $ | 292,935 |  |  |  | — |  |  | $ | — |  |  | $ | (261,723 | ) |  | $ | 31,584 |

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

HERITAGE GLOBAL INC.

CONDENSED CONSOLIDATED S TATEMENTS OF CASH FLOWS

(In thousands of US dollars)

(unaudited)

|  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |
Cash flows provided by (used in) operating activities: |  |  |  |  |  |
Net income |  | $ | 5,523 |  |  | $ | 2,093 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |  |  |  |
Amortization of deferred issuance costs and fees |  |  | 125 |  |  |  | 39 |
Earnings of equity method investments |  |  | (5,960 | ) |  |  | 83 |
Noncash lease expense |  |  | 391 |  |  |  | 408 |
Depreciation and amortization |  |  | 400 |  |  |  | 294 |
Deferred taxes |  |  | 1,371 |  |  |  | (405 | )
Stock-based compensation expense |  |  | 384 |  |  |  | 313 |
Changes in operating assets and liabilities: |  |  |  |  |  |
Accounts receivable |  |  | 1,062 |  |  |  | (1,555 | )
Inventory – equipment |  |  | (1,602 | ) |  |  | (26 | )
Other assets |  |  | 281 |  |  |  | (80 | )
Accounts payable and accrued liabilities |  |  | 1,530 |  |  |  | (1,582 | )
Payables to sellers |  |  | (561 | ) |  |  | (3,308 | )
Lease liabilities |  |  | (373 | ) |  |  | (400 | )
Net cash provided by (used in) operating activities |  |  | 2,571 |  |  |  | (4,126 | )
Cash flows provided by (used in) investing activities: |  |  |  |  |  |
Investment in notes receivable |  |  | (625 | ) |  |  | (5,856 | )
Payments received on notes receivable |  |  | 2,446 |  |  |  | 3,388 |
Investment in equity method investments |  |  | (8,068 | ) |  |  | (1,092 | )
Return of investment in equity method investments |  |  | 2,945 |  |  |  | — |
Cash distributions from equity method investments |  |  | 7,266 |  |  |  | 82 |
Purchase of property and equipment |  |  | (94 | ) |  |  | (1,423 | )
Acquisition, net of cash acquired |  |  | — |  |  |  | (4,318 | )
Cash received on transfer of notes receivable to partners |  |  | — |  |  |  | 1,961 |
Net cash provided by (used in) investing activities |  |  | 3,870 |  |  |  | (7,258 | )
Cash flows (used in) provided by financing activities: |  |  |  |  |  |
Proceeds from debt payable to third parties |  |  | — |  |  |  | 1,300 |
Repayment of debt payable to third parties |  |  | (2,307 | ) |  |  | (1,300 | )
Proceeds from issuance of notes payable to third parties |  |  | — |  |  |  | 2,000 |
Proceeds from issuance of common stock from stock option awards |  |  | 66 |  |  |  | 221 |
Payments of tax withholdings related to cashless exercises of stock option awards |  |  | (44 | ) |  |  | (988 | )
Repurchase of common stock |  |  | (296 | ) |  |  | — |
Net cash (used in) provided by financing activities |  |  | (2,581 | ) |  |  | 1,233 |
Net increase (decrease) in cash and cash equivalents |  |  | 3,860 |  |  |  | (10,151 | )
Cash and cash equivalents as of beginning of period |  |  | 13,622 |  |  |  | 23,385 |
Cash and cash equivalents as of end of period |  | $ | 17,482 |  |  | $ | 13,234 |
Supplemental cash flow information: |  |  |  |  |  |
Cash paid for taxes |  | $ | 276 |  |  | $ | 118 |
Cash paid for interest |  | $ | 106 |  |  | $ | 6 |
Noncash change in Right-of-use assets |  | $ | 630 |  |  | $ | 2,263 |
Noncash change in Lease liabilities |  | $ | 630 |  |  | $ | 2,263 |

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

HERITAGE GLOBAL INC.

NOTES TO CONDENSED CO NSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Note 1 –Basis of Presentation

These consolidated financial statements include the accounts of Heritage Global Inc. together with its subsidiaries, including Heritage Global Partners, Inc. (“HGP”), National Loan Exchange Inc. (“NLEX”), Heritage Global LLC (“HG LLC”), Heritage Global Capital LLC (“HGC”), and Heritage ALT LLC (“ALT”). These entities, collectively, are referred to as “HGI,” the “Company,” “we” or “our” in these consolidated financial statements. These consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), as outlined in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and include the assets, liabilities, revenues, and expenses of all subsidiaries over which HGI exercises control. All significant intercompany accounts and transactions have been eliminated upon consolidation. The Company began its asset liquidation operations in 2009 with the establishment of HG LLC. The business was subsequently expanded by the acquisitions of HGP, NLEX, and ALT in 2012, 2014, and 2021 respectively, and the creation of HGC in 2019. As a result, HGI is positioned to provide an array of value-added capital and financial asset solutions: auction and appraisal services, traditional asset disposition sales, and specialty financing solutions. The Company’s reportable segments consist of both its Financial Assets Division and Industrial Assets Division.

The Company has prepared the condensed consolidated interim financial statements included herein pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). In the opinion of management, these financial statements reflect all adjustments that are necessary to present fairly the results for the interim periods included herein. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are appropriate. These unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022 (the “Form 10-K”).

The results of operations for the three month period ended September 30, 2022 are not necessarily indicative of those operating results to be expected for any subsequent interim period or for the entire year ending December 31, 2022. The accompanying Condensed Consolidated Balance Sheet as of December 31, 2021 has been derived from the audited consolidated balance sheet as of December 31, 2021, contained in the Company’s Form 10-K.

COVID-19

The novel coronavirus (“COVID-19”) pandemic had a negative impact on the Company's performance during 2021 due to evolving travel and work restrictions, stimulus payments and credit policies impacting debt sales by financial institutions, and a delay in the typical process for the sale of certain industrial assets by manufacturing companies.

Going forward, and subject to the caveat below, the Company does not believe the COVID-19 pandemic will have material negative impacts on its financial performance, as the Company expects that the supply of surplus industrial assets will return to pre-pandemic levels and believes that the continuing disruptions to the global supply chain, particularly those involving industrial assets, will further increase demand for U.S.-based surplus assets. Further, as stimulus payments conclude, the Company expects that the COVID-19 pandemic will have the following positive impacts:

•
increased activity for NLEX and HGC due to the resurgence of consumer spending, rising delinquency and charge-off rates, and expanding volumes of nonperforming and charged-off consumer loans; and
•
incremental valuation opportunities for the Company's valuation business as a result of greater focus on collateral on bank balance sheets.

Further surges in COVID-19 infection rates could result in the continuation of stimulus payments and the implementation of additional credit policies impacting debt sales that may result in delayed revenues depending on the scope and magnitude of such policies.

7

Public Offering

On October 6, 2020, the Company completed a public offering (the “2020 Public Offering”) of 5,462,500 shares of its common stock, at a public offering price of $1.75 per share, which included a full exercise of the underwriters’ option to purchase 712,500 additional shares of common stock from the Company. The Company received approximately $8.7 million of net proceeds, after deducting underwriting discounts and commissions, but before offering expenses. During 2021 and the nine months ended September 30, 2022, the Company deployed proceeds to fund the ALT acquisition, as well as various principal transactions in both its Financial Assets and Industrial Assets Divisions.

Repurchase Program

The Company’s Board of Directors authorized a share repurchase program on May 5, 2022 (“2022 Repurchase Program”) which permits the Company to purchase up to an aggregate of $4.0 million in common shares over a three year period ending in June of 2025. As of September 30, 2022, the Company had approximately $3.7 million in remaining aggregate dollar value of shares that may be purchased under the program. There were 0.1 million shares repurchased in the open market for $0.2 million during the three months ended September 30, 2022, and 0.2 million shares repurchased in the open market for $0.3 million during the nine months ended September 30, 2022.

Note 2 – Summary of Significant Accounting Policies

Use of estimates

The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.

Significant estimates include the assessment of collectability of revenue recognized and the valuation of accounts receivable and notes receivable, inventory, investments, goodwill and intangible assets, liabilities, deferred income tax assets and liabilities including projecting future years’ taxable income, and stock-based compensation. These estimates have the potential to significantly impact our consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.

Reclassifications

Certain prior year balances within the consolidated financial statements have been reclassified to conform to current year presentation.

Revenue recognition

The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”).

Services revenue generally consists of commissions and fees from providing auction services, appraisals, brokering of sales transactions, secured lending and providing merger and acquisition advisory services. Asset sales revenue generally consists of proceeds obtained through sales of purchased assets. Revenue is recognized for both services revenue and asset sales revenue based on the ASC 606 standard recognition model, which consists of the following: (1) an agreement exists between two or more parties that creates enforceable rights and obligations, (2) the performance obligations are clearly identified, (3) the transaction price has been determined, (4) the transaction price has been properly allocated to each performance obligation, and (5) the entity satisfies a performance obligation by transferring a promised good or service to a customer for each of the entities.

All services and asset sales revenue from contracts with customers is considered to be within the asset liquidation business, which consists of two reportable segments, the Industrial Assets Division and the Financial Assets Division. Generally, revenue is recognized in the asset liquidation business at the point in time in which the performance obligation has been satisfied. The exception to recognition at a point in time occurs when certain contracts provide for advance payments recognized over a period of time. Services revenue recognized over a period of time is not material in comparison to total revenues (less than 1% of total revenues for the three months ended September 30, 2022), and therefore not reported on a disaggregated basis. Further, as certain contracts

8

stipulate that the customer make advance payments, amounts not recognized within the reporting period are considered deferred revenue and the Company’s “contract liability”. As of September 30, 2022, the deferred revenue balance was approximately $0.4 million and is recorded as a component of accounts payable and accrued liabilities. The deferred revenue balance is primarily related to customer deposits on ALT asset sales. The Company records receivables related to asset liquidation in certain situations based on timing of payments for asset liquidation transactions held at the end of the reporting period; however, revenue is generally recognized in the period that the Company satisfies the performance obligation. The Company does not record a “contract asset” for partially satisfied performance obligations.

For auction services and brokerage sale transactions, funds are typically collected from buyers and are held by the Company on the seller's behalf. The funds are included in Cash and cash equivalents in the Condensed Consolidated Balance Sheets. The Company releases the funds to the seller, less the Company's commission and other fees due, after the buyer has accepted the goods. The amount of cash held on behalf of the sellers is recorded as payables to sellers in the accompanying Condensed Consolidated Balance Sheets.

The Company evaluates revenue from asset liquidation transactions in accordance with the accounting guidance to determine whether to report such revenue on a gross or net basis. The Company has determined that it acts as an agent for its fee based asset liquidation transactions and therefore reports the revenue from these transactions on a net basis.

The Company also earns asset liquidation income through asset liquidation transactions that involve the Company acting jointly with one or more additional purchasers, pursuant to a partnership, joint venture or limited liability company (“LLC”) agreement (collectively, “Joint Ventures”). For these transactions, in which the Company’s ownership share meets the criteria for the equity method investments under ASC 323, the Company does not record asset liquidation revenue or expense. Instead, the Company’s proportionate share of the net income (loss) is reported as earnings of equity method investments. In general, the Joint Ventures apply the same revenue recognition and other accounting policies as the Company.

In 2019, the Company began providing specialty financing solutions to investors in charged-off and nonperforming asset portfolios. Fees collected in relation to the issuance of loans includes loan origination fees, interest income, portfolio monitoring fees, and a backend profit share percentage related to the underlying asset portfolio.

The loan origination fees are offset with any direct origination costs and are deferred upon issuance of the loan and amortized over the lives of the related loans, as an adjustment to interest income. The interest method is used to arrive at periodic interest income, net of fees and costs, that reflects a constant effective yield on the net investment in the loan receivable.

The monitoring fees and the backend profit share are considered a separate earnings process as compared to the origination fees and interest income. Monitoring fees are recorded at the agreed upon rate, and at the moment in which payments are made by the borrower. The backend profit share is recognized in accordance with the agreed upon rate at the time in which the amount is realizable and earned. The recognition policy was established due to the uncertainty of timing of the amount of backend profit share which will be realized.

Future accounting pronouncements

In 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (“ASU 2016-13”), which applies a current expected credit loss model based on expected losses rather than incurred losses. The expected credit losses, and subsequent adjustments to such losses, will be recorded through an allowance account that is deducted from, or added to, the amortized cost basis of the financial asset, with the net carrying value of the financial asset presented on the consolidated balance sheet at the amount expected to be collected. ASU 2016-13 eliminates the current accounting model for loans and debt securities acquired with deteriorated credit quality under ASC Topic 310-30, Receivables – Loans and Debt Securities Acquired with Deteriorated Credit Quality, which provides authoritative guidance for the accounting of the Company’s notes receivable. With respect to smaller reporting companies, the amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will complete its evaluation on the impact of the new guidance on its consolidated financial statements in the fourth quarter ended December 31, 2022.

9

Note 3 – Notes Receivable, net

The Company’s notes receivable balance consists of loans to buyers of charged-off receivable portfolios. As of September 30, 2022 and December 31, 2021, the Company’s outstanding notes receivables, net of unamortized deferred fees and costs on originated loans, were $2.1 million and $4.0 million, respectively. During the nine months ended September 30, 2022, the Company issued notes receivable of approximately $0.6 million, which was offset by principal payments made by borrowers of approximately $2.4 million and adjustments to the deferred fees and costs balance of approximately $0.1 million.

As of September 30, 2022 and December 31, 2021, the Company did no t record an allowance for credit losses related to notes receivable outstanding.

Note 4 – Stock-based Compensation

Options

As of September 30, 2022, the Company had four stock-based compensation plans, which are described more fully in Note 17 to the audited consolidated financial statements for the year ended December 31, 2021, contained in the Company’s Form 10-K.

During the nine months ended September 30, 2022, the Company issued options to purchase 279,500 shares of common stock to certain of the Company's employees. During the same period, the Company cancelled options to purchase 95,625 shares of common stock, of which 55,625 were as a result of employee resignations and 40,000 were options issued to non-employee directors and subsequently canceled.

The following summarizes the changes in common stock options for the nine months ended September 30, 2022:

|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value (In thousands) |
Outstanding as of December 31, 2021 |  |  | 2,193,288 |  |  | $ | 1.23 |  |  |  |  |  |  |
Granted |  |  | 279,500 |  |  | $ | 1.62 |  |  |  |  |  |  |
Exercised |  |  | (339,125 | ) |  | $ | 0.50 |  |  |  |  |  |  |
Forfeited |  |  | (95,625 | ) |  | $ | 1.77 |  |  |  |  |  |  |
Outstanding as of September 30, 2022 |  |  | 2,038,038 |  |  | $ | 1.38 |  |  |  | 7.38 |  |  | $ | 938 |
Options exercisable as of September 30, 2022 |  |  | 980,163 |  |  | $ | 0.96 |  |  |  | 6.02 |  |  | $ | 737 |

The Company recognized stock-based compensation expense related to common stock options of $0.3 million for the nine months ended September 30, 2022. As of September 30, 2022, there was approximately $1.0 million of unrecognized stock-based compensation expense related to unvested common stock options outstanding, which is expected to be recognized over a weighted average period of 2.8 years.

At the Company's 2022 Annual Meeting of Shareholders, the Company's shareholders approved the 2022 Heritage Global Inc. Equity Incentive Plan, which replaces the Heritage Global Inc. 2016 Plan and authorized the issuance of an aggregate of 3.5 million shares of Common Stock for awards made after June 8, 2022. As of September 30, 2022, the Company issued options to purchase 144,500 shares of common stock to certain of the Company's employees under this plan.

Restricted Stock

Restricted stock awards represent a right to receive shares of common stock at a future date determined in accordance with the participant’s award agreement. There is no exercise price and no monetary payment required for receipt of restricted stock awards or the shares issued in settlement of the award. Instead, consideration is furnished in the form of the participant’s services to the Company. Compensation cost for these awards is based on the fair value of the shares of common stock on the date of grant and recognized as compensation expense on a straight-line basis over the requisite service period.

10

On June 1, 2018, the Company granted 600,000 shares of Company restricted common stock in connection with the Addenda to the Employment Agreements of David Ludwig and Tom Ludwig. The shares are subject to certain restrictions on transfer and a right of repurchase over five years, ending May 31, 2023, and require a continued term of service to the Company. Stock-based compensation expense related to the restricted stock awards, calculated by using the grant date fair value of $0.43 per share, was $38,700 for the nine months ended September 30, 2022. The unrecognized stock-based compensation expense as of September 30, 2022 was approximately $34,400.

On March 30, 2021, the Company and Scott West entered into a Separation Agreement and General Release (the “Separation Agreement”). Under the terms of the Separation Agreement, Mr. West’s separation from the Company was effective on March 31, 2021. On April 8, 2021, the Company granted 25,000 shares of the Company’s restricted common stock, which will be forfeited to the Company during the two years following the effective date of the Separation Agreement in the event Mr. West breaches the terms of the Separation Agreement. In addition, the Separation Agreement provides for customary mutual releases by the Company and Mr. West, and the Separation Agreement includes confidentiality, non-disparagement and other obligations. The full amount of the restricted common stock was expensed as of March 31, 2021.

On August 3, 2022, the Company granted 115,000 shares of Company restricted common stock to non-executive directors under the 2022 Heritage Global Inc. Equity Incentive Plan. Of the shares of Company restricted common stock granted during the nine months ended September 30, 2022, 40,000 shares were granted with a vesting term that was completed prior to the grant date due to a delay in the Company’s ability to grant such shares, and the remaining 75,000 shares will vest in full on March 31, 2023. We determined the fair value of the shares awarded by using the closing price of our common stock as of the grant date. Stock-based compensation expense related to the restricted stock awards, calculated by using the grant date fair value of $1.58 per share, was $92,800 for the nine months ended September 30, 2022. The unrecognized stock-based compensation expense as of for the nine months ended September 30, 2022, was approximately $88,900.

Note 5 – Lessor Arrangement

In June 2019, the Company, with certain partners, entered into agreements to lease, with a purchase option, a fully functional manufacturing building, including all machinery and equipment held within. The assets under lease relate to the Company’s purchase, with certain partners, of a pharmaceutical campus in Huntsville, Alabama, as disclosed in the Company’s Form 10-K. The lessee is obligated to make monthly lease payments over a ten-year period, totaling approximately $13.2 million for the real estate portion, and monthly lease payments over a six-year period totaling approximately $9.7 million for the machinery and equipment. The lessor arrangement is classified as a sales-type lease, and, therefore, the present value of future lease payments was recognized as revenue and a lease receivable as of the effective date.

The real estate portion of the lease arrangement is owned by CPFH LLC, the joint venture, and is accounted for under the equity method where the Company’s share in earnings from equity method investments is shown in one line item on the Condensed Consolidated Income Statement. Refer to Note 6 for further information.

The machinery and equipment portion of the arrangement is jointly owned by all the partners of CPFH LLC, apart from the joint venture entity. Therefore, the Company has derecognized the leased asset of approximately $0.9 million and recognized as revenue approximately $1.2 million, which represents the present value of future lease payments and a lease receivable included in the accounts receivable line item on the Condensed Consolidated Balance Sheet, consistent and reflective of its business model for asset sales.

The purchase option for both the real estate and machinery and equipment could be exercised at any time on or after December 1, 2019, and before May 31, 2021, for a total purchase price of $20.0 million, of which $12.0 million and $8.0 million are allocated to the real estate and machinery and equipment, respectively. On May 31, 2021, the lessee delivered written notice to exercise the purchase option. The lessee confirmed that its intention was to exercise the option, however, was unable to complete the transaction before the purchase option’s original expiration date of November 30, 2021. CPFH LLC and lessee negotiated an amendment to the purchase option in March of 2022, increasing the purchase price for the real estate to $15.0 million. On June 30, 2022, the lessee exercised its purchase option by completing the real estate transaction and terminating the lease.

11

Note 6 – Equity Method Investments

In November 2018, CPFH LLC, of which the Company holds a 25% share, was formed to purchase certain real estate assets among partners in a joint venture. In March 2020, HGC Origination I LLC and HGC Funding I LLC were formed as joint ventures with a partner for purposes of conducting business relating to the sourcing, origination and funding of loans to debt purchasing clients. In April 2022, KNFH LLC, of which the Company holds a 25% share, was formed to purchase certain real estate assets and machinery and equipment among partners in a joint venture. CPFH LLC and KNFH LLC are joint ventures formed in connection with the Company’s Industrial Assets Division, whereas HGC Origination I LLC and HGC Funding I LLC were formed in connection with its Financial Assets Division.

The table below details the Company’s joint venture revenues and earnings during the nine months ended September 30, 2022 and 2021 (in thousands):

|  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |
Revenues: |  |  |  |  |  |
Oak Grove Asset Acquisitions LP |  | $ | — |  |  | $ | 5 |
CPFH LLC |  |  | 31,072 |  |  |  | 350 |
KNFH LLC |  |  | 16,882 |  |  |  | — |
HGC Funding I LLC and Origination I LLC |  |  | 1,611 |  |  |  | 73 |
Total revenues |  | $ | 49,565 |  |  | $ | 428 |
Operating (loss) income: |  |  |  |  |  |
Oak Grove Asset Acquisitions LP |  | $ | — |  |  | $ | 4 |
CPFH LLC |  |  | 15,357 |  |  |  | (402 | )
KNFH LLC |  |  | 6,915 |  |  |  | — |
HGC Funding I LLC and Origination I LLC |  |  | 1,589 |  |  |  | 51 |
Total operating (loss) income |  | $ | 23,861 |  |  | $ | (347 | )

The table below details the summarized components of assets and liabilities of the Company’s joint ventures, as of September 30, 2022 and December 31, 2021 (in thousands):

|  | September 30, |  |  | December 31, |
|  | 2022 |  |  | 2021 |
Assets: |  |  |  |  |  |
CPFH LLC |  |  | 779 |  |  |  | 11,789 |
KNFH LLC |  |  | 2,712 |  |  |  | — |
HGC Funding I LLC and Origination I LLC |  |  | 31,790 |  |  |  | 10,476 |
Total assets |  | $ | 35,281 |  |  | $ | 22,265 |
Liabilities: |  |  |  |  |  |
CPFH LLC |  |  | 138 |  |  |  | 6,099 |
KNFH LLC |  |  | 43 |  |  |  | — |
HGC Funding I LLC and Origination I LLC |  |  | — |  |  |  | — |
Total liabilities |  | $ | 181 |  |  | $ | 6,099 |

12

Note 7 – Earnings Per Share

The Company is required in periods in which it has net income to calculate basic earnings per share (“basic EPS”) using the two-class method. The two-class method is required because the Company’s shares of Series N preferred shares, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock. Under the two-class method, earnings for the period are allocated on a pro-rata basis to the common and preferred stockholders. The weighted-average number of common and preferred shares outstanding during the period is then used to calculate basic EPS for each class of shares. For the three and nine months ended September 30, 2022, the earnings allocated to the preferred shares outstanding was not material.

In periods in which the Company has a net loss, basic loss per share is calculated by dividing the loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. The two-class method is not used in periods in which the Company has a net loss because the preferred stock does not participate in losses.

Stock options and other potential common shares are included in the calculation of diluted earnings per share (“diluted EPS”), since they are assumed to be exercised or converted, except when their effect would be anti-dilutive. The table below shows the calculation of the shares used in computing diluted EPS.

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
Weighted Average Shares Calculation: |  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Basic weighted average shares outstanding |  |  | 36,084,696 |  |  |  | 35,805,227 |  |  |  | 36,014,439 |  |  |  | 35,285,128 |
Treasury stock effect of common stock options and restricted stock awards |  |  | 1,136,734 |  |  |  | 1,285,067 |  |  |  | 858,538 |  |  |  | 1,282,585 |
Diluted weighted average common shares outstanding |  |  | 37,221,430 |  |  |  | 37,090,294 |  |  |  | 36,872,977 |  |  |  | 36,567,713 |

For the nine months ended September 30, 2022 and 2021, there were potential common shares of 0.9 million and approximately 0.4 million, respectively, that were excluded from the computation of diluted EPS, as the inclusion of such common shares would have been anti-dilutive. For the three months ended September 30, 2022 and 2021, there were potential common shares of 0.8 million and 0.4 million, respectively, that were excluded.

Note 8 – Leases

The Company leases office and warehouse space primarily in four locations: Del Mar, CA; Hayward, CA; San Diego, CA and Edwardsville, IL. As each contract does not meet any of the four criteria of ASC 842 for financing lease classification, the Company has determined that each lease arrangement should be classified as an operating lease.

On October 27, 2020, the Company entered into an agreement (the “Lease”) with Hayward FGHK Industrial, LLC (“Landlord”) pursuant to which the Company leases 30,321 square feet of industrial space in Hayward, California from Landlord. The Lease has a commencement date of April 1, 2021, and an initial term of ninety (90) months, unless terminated earlier by either party pursuant to the terms of the Lease. The Lease provides for an initial monthly base rent of $27,289, which increases on an annual basis to $33,562 per month in the final year. In addition, the Company is obligated to pay its share of maintenance costs of common areas.

On August 12, 2022, the Company entered into an agreement (the “Lease”) with Liberty Industrial Park, LLC (“Landlord”) pursuant to which the Company leases 6,627 square feet of industrial space in San Diego, California from Landlord. The Lease has a commencement date of September 1, 2022. The Lease provides for an initial monthly base rent of $11,266, which increases on an annual basis to $13,180 per month in the final year. In addition, the Company is obligated to pay its share of maintenance costs of common areas.

13

The right-of-use assets and lease liabilities for each location are as follows (in thousands):

|  | September 30, |  |  | December 31, |
Right-of-use assets: |  | 2022 |  |  | 2021 |
Del Mar, CA |  | $ | 371 |  |  | $ | 477 |
Hayward, CA |  |  | 1,867 |  |  |  | 2,064 |
San Diego, CA |  |  | 618 |  |  |  | — |
Edwardsville, IL |  |  | 77 |  |  |  | 153 |
|  | $ | 2,933 |  |  | $ | 2,694 |
|  | September 30, |  |  | December 31, |
Lease liabilities: |  | 2022 |  |  | 2021 |
Del Mar, CA |  | $ | 398 |  |  | $ | 506 |
Hayward, CA |  |  | 1,913 |  |  |  | 2,089 |
San Diego, CA |  |  | 619 |  |  |  | — |
Edwardsville, IL |  |  | 77 |  |  |  | 155 |
|  | $ | 3,007 |  |  | $ | 2,750 |

The Company’s leases generally do not provide an implicit rate, and, therefore, the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used its incremental borrowing rate as of January 1, 2019 for operating leases that commenced prior to that date. As of January 1, 2019, the Company’s incremental borrowing rate was 5.25%. For leases commencing after January 1, 2019 the Company uses its incremental borrowing rate at time of commencement. On April 1, 2021 and September 1, 2022 the Company’s incremental borrowing rate was 4.95% and 5.5%, respectively.

Lease expense for leases determined to be operating leases is recognized on a straight-line basis over the lease term. For the nine month periods ended September 30, 2022 and 2021, lease expense was approximately $0.5 million. As of September 30, 2022, undiscounted future minimum lease payments related to leases that have initial or remaining lease terms in excess of one year are as follows (in thousands):

2022 (remainder of year from October 1, 2022 to December 31, 2022) |  | $ | 176 |
2023 |  |  | 705 |
2024 |  |  | 675 |
2025 |  |  | 546 |
2026 |  |  | 531 |
Thereafter |  |  | 808 |
Total undiscounted future minimum lease payments |  |  | 3,441 |
Less imputed interest |  |  | (434 | )
Present value of lease liabilities |  | $ | 3,007 |

Note 9 – Intangible Assets and Goodwill

Identifiable intangible assets

The Company’s identifiable intangible assets are associated with its acquisitions of HGP in 2012, NLEX in 2014 and ALT in 2021, as shown in the table below (in thousands except for lives) and are amortized using the straight-line method over their remaining estimated useful lives. The Company’s tradename that was acquired as part of the acquisition of NLEX in 2014 has an indefinite life and therefore is not amortized.

14

|  | Remaining |  |  | Carrying Value |  |  |  |  |  | Carrying Value |
|  | Life |  |  | December 31, |  |  |  |  |  | September 30, |
Amortized Intangible Assets |  | (years) |  |  | 2021 |  |  | Amortization |  |  | 2022 |
Customer Relationships (HGP) |  |  | 0.3 |  |  | $ | 30 |  |  | $ | (22 | ) |  | $ | 8 |
Trade Name (HGP) |  |  | 2.3 |  |  |  | 386 |  |  |  | (96 | ) |  |  | 290 |
Trade Name (ALT) |  |  | 18.9 |  |  |  | 639 |  |  |  | (24 | ) |  |  | 615 |
Vendor Relationship (ALT) |  |  | 3.9 |  |  |  | 1,073 |  |  |  | (173 | ) |  |  | 900 |
Total |  |  |  |  |  | 2,128 |  |  |  | (315 | ) |  |  | 1,813 |
Unamortized Intangible Assets |  |  |  |  |  |  |  |  |  |  |  |
Trade Name (NLEX) |  | NA |  |  |  | 2,437 |  |  |  | — |  |  |  | 2,437 |
Total |  |  |  |  |  | 2,437 |  |  |  | — |  |  |  | 2,437 |
Total |  |  |  |  | $ | 4,565 |  |  | $ | (315 | ) |  | $ | 4,250 |

Amortization expense during the nine months ended September 30, 2022 and 2021 was $0.3 and $0.2 million respectively.

As of September 30, 2022, the estimated amortization expense for the remainder of the current fiscal year and the next five fiscal years and thereafter is shown below (in thousands):

Year |  | Amount |
2022 (remainder of year from October 1, 2022 to December 31, 2022) |  | $ | 105 |
2023 |  |  | 391 |
2024 |  |  | 391 |
2025 |  |  | 263 |
2026 |  |  | 186 |
Thereafter |  |  | 477 |
Total |  | $ | 1,813 |

Goodwill

The Company’s goodwill is related to its asset liquidation business and is comprised of goodwill from the acquisitions of HGP in 2012, NLEX in 2014 and ALT in 2021, as shown in the table below (in thousands). There were no additions to goodwill and no impairment losses to the carrying amount of goodwill during the nine months ended September 30, 2022.

Acquisition |  | September 30, 2022 |  |  | December 31, 2021 |
ALT |  | $ | 1,861 |  |  | $ | 1,861 |
HGP |  |  | 2,040 |  |  |  | 2,040 |
NLEX |  |  | 3,545 |  |  |  | 3,545 |
Total goodwill |  | $ | 7,446 |  |  | $ | 7,446 |

15

Note 10 – Debt

Outstanding debt as of September 30, 2022 and December 31, 2021 is summarized as follows (in thousands):

|  | September 30, 2022 |  |  | December 31, 2021 |
Current: |  |  |  |  |  |
Third party debt |  | $ | 531 |  |  | $ | 2,479 |
Non-current: |  |  |  |  |  |
Third party debt |  |  | 993 |  |  |  | 1,352 |
Total debt |  | $ | 1,524 |  |  | $ | 3,831 |

On May 5, 2021, the Company entered into a promissory note, business loan agreement, commercial security agreement and pledge agreement (the “2021 Credit Facility”) with C3bank, National Association for a $10.0 million revolving line of credit. The 2021 Credit Facility matures on May 7, 2023. The Company is permitted to use the proceeds of the loan solely for its business operations. The 2021 Credit Facility accrues at a variable interest rate, which is based on the rate of interest last quoted by The Wall Street Journal as the “prime rate,” plus a margin of 1.70% (such rate not to be less than 4.950% per annum). The Company pays interest on the 2021 Credit Facility in regular monthly payments, which began on June 11, 2021. The 2021 Credit Facility also provides for a minimum fee, which is offset by interest payments. The Company may prepay the 2021 Credit Facility without penalty and may convert up to $5.0 million of revolving debt into term debt. The Company is the borrower under the 2021 Credit Facility. The 2021 Credit Facility is secured by a security interest in certain of the Company’s and its certain subsidiaries’ current and future tangible and intangible assets, inventory, chattel paper, accounts, equipment and general intangibles and a pledge of the equity of the direct and indirect subsidiaries of the Company. The availability of additional draws under the 2021 Credit Facility is conditioned, among other things, on the compliance with certain customary representations and warranties, including default, insolvency or bankruptcy, material adverse change in financial condition and any guarantor’s attempt to revise its guarantee. The agreement governing the 2021 Credit Facility also contains customary affirmative covenants regarding, among other things, the maintenance of records, maintenance of certain insurance coverage, compliance with governmental requirements and maintenance of several financial covenants. The 2021 Credit Facility contains certain customary financial covenants and negative covenants that, among other things, include restrictions on the Company’s ability to create, incur or assume indebtedness for borrowed money, including capital leases or to sell, transfer, mortgage, assign, pledge, lease, grant a security interest in, or encumber any of the Company’s assets. The Company had no outstanding balance as of September 30, 2022.

On August 23, 2022, the Company entered into a Loan Modification Agreement and Reaffirmation of Loan (the “Modification Agreement”), effective as of April 1, 2022, by and between the Company and C3bank, National Association (the “Lender”). The Modification Agreement modifies and reaffirms that certain promissory note, business loan agreement, commercial security agreement and pledge agreement, dated as of May 5, 2021, by and between the Company and Lender (collectively, the “Loan Agreement”), whereby Lender agreed to make a revolving line of credit to Borrower in the maximum principal amount of $10.0 million. The Modification Agreement modifies and amends the Loan Agreement to provide for, among other things, the arrangement of the Loan Agreement’s financial covenants, which remain unchanged, into two categories: (i) financial covenants used to resize the maximum principal amount available to the Company as of the date of determination (as determined by Lender in its sole discretion), and (ii) financial covenants to be maintained by the Company during the term of the Loan Agreement.

On August 23, 2021, the Company entered into a $2.0 million subordinated promissory note with an interest rate of 3% per annum and a maturity date of August 23, 2025 (the “ALT Note”) as part of the aggregate purchase price paid to acquire certain assets and liabilities of American Laboratory Trading. The ALT Note requires 48 equal installments of approximately $44,000 on the first day of each month, beginning the next month succeeding the closing date of August 23, 2021 with the final payment due on August 23, 2025. The outstanding balance of the ALT Note as of September 30, 2022 was $1.5 million.

Note 11 – Income Taxes

As of September 30, 2022, the Company had aggregate tax net operating loss carry forwards of approximately $77.8 million ($62.2 million of unrestricted net operating tax losses and approximately $15.6 million of restricted net operating tax losses). Substantially all of the net operating loss carry forwards expire between 2024 and 2037. The Company’s utilization of restricted net operating tax loss carry forwards against future income for tax purposes is restricted pursuant to the “change in ownership” rules in Section 382 of the Internal Revenue Code.

The reported tax expense varies from the amount that would be provided by applying the statutory U.S. Federal income tax rate to the income from operations before taxes primarily as a result of the impact of state income taxes.

16

The Company records net deferred tax assets to the extent that it believes such assets will more likely than not be realized. As a result of cumulative losses and uncertainty with respect to future taxable income, the Company has provided a partial valuation allowance against its net deferred tax assets as of September 30, 2022 and December 31, 2021.

Note 12 – Related Party Transactions

As part of the operations of NLEX, the Company leases office space in Edwardsville, IL that is owned by David Ludwig, the Company’s President of its Financial Assets Division and a member of its board of directors. The total amount paid to the related party for both nine month periods ended September 30, 2022 and 2021 was approximately $83,000 and $82,000 respectively, and is included in selling, general and administrative expenses the Condensed Consolidated Income Statements. All lease payments during the nine months ended September 30, 2022 and the year ended December 31, 2021 were made to Mr. Ludwig. On June 1, 2018, the Company amended its lease agreement with David Ludwig to extend the term of the lease to May 31, 2023 and to set the rent amounts for the new term.

Note 13 – Segment Information

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable segments. The Company manages its business primarily on differentiated revenue streams for services offered. The Company’s reportable segments consist of the Industrial Assets Division and Financial Assets Division. The Industrial Assets Division advises enterprise and financial customers on the sale of industrial assets mostly from surplus and sometimes distressed circumstances while acting as an agent, guarantor or principal in the sale. The Financial Assets Division provides liquidity to issuers of consumer credit that are looking to monetize nonperforming and charged-off loans — loans that creditors have written off as uncollectable. Nonperforming and charged-off loans typically originate from banks that issue unsecured consumer credit.

The Company evaluates the performance of its reportable segments based primarily on net operating income. Further, the Company does not utilize segmented asset information to evaluate the performance of its reportable segments and does not include intercompany transfers between segments for management reporting purposes.

The following table sets forth certain financial information for the Company's reportable segments (in thousands):

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Industrial Assets Division: |  |  |  |  |  |  |  |  |  |  |  |
Net operating income |  | $ | 3,058 |  |  | $ | 765 |  |  | $ | 7,247 |  |  | $ | 2,538 |
Financial Assets Division: |  |  |  |  |  |  |  |  |  |  |  |
Net operating income |  | $ | 1,566 |  |  | $ | 449 |  |  | $ | 3,480 |  |  | $ | 1,372 |
Corporate and Other: |  |  |  |  |  |  |  |  |  |  |  |
Net operating loss |  | $ | (1,150 | ) |  | $ | (681 | ) |  | $ | (2,754 | ) |  | $ | (2,258 | )
Consolidated: |  |  |  |  |  |  |  |  |  |  |  |
Net operating income |  | $ | 3,474 |  |  | $ | 533 |  |  | $ | 7,973 |  |  | $ | 1,652 |

17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read in conjunction with the information contained in the unaudited condensed consolidated interim financial statements of Heritage Global Inc. (together with its consolidated subsidiaries, “we”, “us”, “our” or the “Company”) and the related notes thereto for the three and nine month periods ended September 30, 2022 and 2021, appearing elsewhere herein, and in conjunction with the Management’s Discussion and Analysis of Financial Condition and Results of Operations set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (“SEC”) on March 17, 2022 (the “Form 10-K”).

Forward Looking Information

This Quarterly Report on Form 10-Q contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 that are based on management’s exercise of business judgment as well as assumptions made by, and information currently available to, management. When used in this document, the words “may,” "will,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” and words of similar import, are intended to identify any forward-looking statements. You should not place undue reliance on these forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These statements are subject to certain risks, uncertainties, and assumptions, including the important factors noted under Item 1A “Risk Factors” in our Form 10-K, and as noted below. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, our actual results could differ materially from those anticipated in these forward-looking statements. We undertake no obligation, and do not intend, to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of any unanticipated events. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize.

Overview, History and Recent Developments

Heritage Global Inc. (“HGI”) was incorporated in the State of Florida in 1983 under the name “MedCross, Inc.” The Company’s name was changed to “I-Link Incorporated” in 1997, to “Acceris Communications Inc.” in 2003, to “C2 Global Technologies Inc.” in 2005, to “Counsel RB Capital Inc.” in 2011, and to “Heritage Global Inc.” effective in 2013. The most recent name change more closely identifies the Company with its core auction business, Heritage Global Partners, Inc. (“HGP”).

In 2014, HGI acquired all of the issued and outstanding capital stock in National Loan Exchange, Inc. (“NLEX”), a broker of charged-off receivables in the United States and Canada. As a result of this acquisition, NLEX operates as one of our wholly-owned divisions.

In 2019, the Company formed Heritage Global Capital LLC (“HGC”), a wholly-owned subsidiary of HGI, in order to provide specialty financing solutions to investors in charged-off and nonperforming asset portfolios.

In 2021, HGI acquired certain assets and liabilities of American Laboratory Trading, one of the largest suppliers of premium refurbished lab equipment in North America and a key provider of surplus asset services for the life sciences. As a result of this acquisition, American Laboratory Trading operates as one of our wholly-owned divisions, ALT.

18

The organization chart below outlines our basic domestic corporate structure as of September 30, 2022.

|  |  |  | Heritage Global Inc. |  |  |  |  |  |  |
|  |  |  | (Florida) (1) |  |  |  |  |  |  |
|  | 100% |  |  | 100% |  |  | 100% |  |  | 100% |
| Heritage Global Partners, Inc. (California) (2) |  | Heritage Global LLC (Delaware) (3) |  | National Loan Exchange, Inc. (Illinois) (5) |  | Heritage Global Capital LLC (Delaware)(6) |
|  |  |  |  | 100% |  |  |  |  |  |  |
|  |  |  | Heritage ALT LLC (Delaware) (4) |  |  |  |  |  |  |

(1) Registrant.

(2) Full service global auction, appraisal and asset advisory company that also acquires and monetizes distressed and surplus assets.

(3) Holding Company.

(4) Supplier of refurbished lab equipment.

(5) Broker of charged-off and nonperforming receivables.

(6) Specialty financing solutions for charged-off and nonperforming asset portfolios.

COVID-19

The novel coronavirus (“COVID-19”) pandemic had a negative impact on our performance during 2021 due to evolving travel and work restrictions, stimulus payments and credit policies impacting debt sales by financial institutions, and a delay in the typical process for the sale of certain industrial assets by manufacturing companies.

Going forward, and subject to the caveat below, we do not believe the COVID-19 pandemic will have material negative impacts on our financial performance, as we expect that the supply of surplus industrial assets will return to pre-pandemic levels and the continuing disruptions to the global supply chain, particularly those involving industrial assets, will further increase demand for U.S.-based surplus assets. Further, as stimulus payments conclude, we expect that the COVID-19 pandemic will have the following positive impacts:

•
increased activity for NLEX and HGC due to the resurgence of consumer spending, rising delinquency and charge-off rates, and expanding volumes of nonperforming and charged-off consumer loans; and
•
incremental valuation opportunities for our valuation business as a result of greater focus on collateral on bank balance sheets.

Further surges in COVID-19 infection rates could result in the continuation of stimulus payments and the implementation of additional credit policies impacting debt sales that may result in delayed revenues depending on the scope and magnitude of such policies.

Industry and Competition

Our asset liquidation business consists primarily of the auction, appraisal and asset advisory services provided by our Industrial Assets Division and the accounts receivable brokerage and specialty financing services provided by our Financial Assets Division, each of which is further described below. Our asset liquidation business also includes the purchase and sale, including at auction, of industrial machinery and equipment, real estate, inventories, accounts receivable and distressed debt. The market for these services and assets is highly fragmented. To acquire auction or appraisal contracts, or assets for resale, we compete with other liquidators, auction companies, dealers and brokers. We also compete with them for potential purchasers. Some competitors have significantly greater financial and marketing resources and name recognition.

19

We believe that our business is positioned to grow in all economic cycles. As the economy encounters situations of recession, flattening yield curves and rising credit costs, the asset liquidation business may experience wider margins on principal asset sales, a favorable lending cycle for charged-off and nonperforming asset portfolios, higher volumes of nonperforming assets and building surplus inventories and bankruptcies. In times of economic growth, our asset liquidation business has demonstrated its ability to experience growth based on our competitive advantages in the industry, including our domain expertise related to deal sourcing and execution capabilities, our diversification of integrated service platforms and our experience across underserved markets. We intend to continue to leverage our competitive advantages to grow within each service line and across platforms through increasing synergies, maintaining high incremental margins, improving earnings predictability, strengthening financial metrics reflected on our balance sheet and managing expenses.

Our business strategy includes the option of partnering with one or more additional purchasers, pursuant to a partnership, joint venture or limited liability company agreement (collectively, “Joint Ventures”). These Joint Ventures give us access to more opportunities, helping to mitigate some of the competition from the market’s larger participants and contribute to our objective to be the leading resource for clients requiring financial and industrial asset solutions.

Our Competitive Strengths

We believe we have attributes that differentiate us from our competitors and provide us with significant competitive advantages. Our key competitive strengths are described below.

Differentiated Business Model. We believe we have diversified business lines serving the financial and industrial asset liquidation market. We have multiple revenue streams in our brokerage and principal based auction services, advisory services and secured lending services. Further, our business is event-driven and we have repeat, forward-flow contracts in place with industry leading customers. We expect to drive growth in our revenue streams by taking different roles, and using partners as needed.

Compelling Macro Growth Drivers. Consumer lending and resulting charge-offs are expected to continue their upward trend to meet, and possibly exceed, pre-pandemic level which we believe will drive an increased supply of non-performing consumer loans. Additionally, we believe an active market for mergers and acquisitions in manufacturing industries drives demand for industrial asset liquidations and our services. The market in which we operate is highly fragmented, presenting a continued opportunity for the Company to increase market share and drive consolidation.

High Return on Invested Capital. We believe we have an opportunity to drive improved auction economics by serving more frequently in the role of principal in industrial asset transactions, rather than the lower margin role of broker.

Strong Management Team. We have built an experienced executive-level management team with deep domain expertise. Our President and Chief Executive Officer, Ross Dove, is a third-generation auctioneer and a pioneering innovator in applying technology to the asset liquidation industry. Mr. Dove began his career in the auction business over thirty years ago, beginning with a small family-owned auction house and helping to expand it into a global firm, DoveBid, which was sold to a third party in 2008. In addition, our senior management team has deep domain expertise in both industrial asset and financial asset transactions. On September 17, 2020, we entered into an Employment Agreement with Kirk Dove, the former President and Chief Operating Officer of the Company. Upon his resignation, Kirk Dove continued his employment with us in an advisory capacity and is expected to do so until December 31, 2024. Also, during 2020, Nick Dove was appointed as President, Industrial Assets Division, and David Ludwig was appointed as President, Financial Assets Division. Nick Dove previously served as Executive Vice President of Sales of Heritage Global Partners since August 2017. David Ludwig previously served as President of NLEX, a wholly owned subsidiary of the Company, and has served in such capacity since the Company acquired NLEX in 2014.

Financial Assets Division

Our Financial Assets Division provides liquidity to issuers of consumer credit that are looking to monetize nonperforming and charged-off loans — loans that creditors have written off as uncollectable. Nonperforming and charged-off loans typically originate from banks that issue unsecured consumer credit.

Through NLEX, we act as an advisor for sales of charged-off and nonperforming asset portfolios via an electronic auction exchange platform for banks, the U.S. government, and other debt holders throughout the United States and Canada. Since the 1980s, NLEX has sold over $150 billion face value of performing, nonperforming and charged-off assets. NLEX sales are concentrated in online, automotive, consumer credit card, student loan and real estate charge-offs. The typical credit we broker sells at a deep discount to face value, and we typically receive a commission for these services from both buyers and sellers. We have existing relationships with high quality, top-tier and mid-tier debt buyers. NLEX is in the process of expanding into the FinTech lenders, peer-to-peer

20

lending and Buy Now Pay Later sectors, where we believe NLEX has opportunity for significant growth. In addition, we plan to add post-sale initiatives, making our services more attractive to our customers as compared to our competitors.

Through HGC, we provide specialty financing solutions to investors in charged-off and nonperforming asset portfolios. Since the inception of HGC in 2019, we have issued $63.2 million in total loans to investors by both self-funded loans and in partnership with senior lenders. Our portion of the total loans funded since inception is $21.5 million. Our income from secured lending consists of upfront fees, interest income, monthly monitoring fees and backend profit share. In general, we expect to earn an annual rate of return on our share of notes receivable outstanding of approximately 20% or more based on established terms of the loans funded and performance of collections.

Our management team has decades of domain expertise with the ability to leverage extensive funding activity and widespread industry relationships. We believe we have the opportunity for growth through increased penetration of the underserved market of mid-tier buyers of charged-off receivables, providing more economic financing options and a greater variety of funding solutions to our customers.

Industrial Assets Division

Our Industrial Assets Division advises enterprise and financial customers on the sale of industrial assets mostly from surplus and sometimes distressed circumstances while acting as an agent, guarantor or principal in the sale. The fees for our services typically range from 15–50%, depending on our role and the transaction. This division predominantly targets sellers of surplus or distressed “inside the building” assets. Our buyers consist of both end-users and dealers. The acquisition of ALT further strengthens our service offering in the biotech and pharma sectors, which have been key verticals over the past decade.

Our management team has decades of domain expertise with the ability to leverage extensive industry relationships, real time access to databases of buyers and sales, as well as a deep understanding of the underlying asset value across the more than 25 industrial sectors in which we operate. We believe we have the opportunity for growth in our auction services through our ability to secure ongoing contracts with large multinational sellers, to be a first mover in emerging sectors, and to gain market share in sectors in which we are currently less active. Our extensive network and ability to find and source new opportunities are key factors for expansion. We believe we have the opportunity for growth in our valuation services through the addition of incremental bank-approved vendor lists, geographic expansion and through deeper penetration with our existing bank relationships.

Government Regulation

We are subject to federal, state and local consumer protection laws, including laws protecting the privacy of customer non-public information and regulations prohibiting unfair and deceptive trade practices. Many jurisdictions also regulate “auctions” and “auctioneers” and may regulate online auction services. These consumer protection laws and regulations could result in substantial compliance costs and could interfere with the conduct of our business.

Legislation in the United States has increased public companies’ regulatory and compliance costs as well as the scope and cost of work provided by independent registered public accountants and legal advisors. As regulatory and compliance guidelines continue to evolve, we may incur additional costs in the future, which may or may not be material, in order to comply with legislative requirements or rules, pronouncements and guidelines by regulatory bodies.

Critical Accounting Policies and Estimates

Management’s Discussion and Analysis of Financial Condition and Results of Operations references our unaudited condensed consolidated interim financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). This requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are considered to be reasonable under the circumstances. Actual results could differ from those estimates.

Significant estimates required in the preparation of the unaudited condensed consolidated interim financial statements included in this quarterly report include the assessment of collectability of revenue recognized, and the valuation of accounts receivable, inventory, other assets, right-of-use assets, goodwill, intangible assets, liabilities, deferred income tax assets and liabilities and stock-based compensation. These estimates are considered significant either because of the significance of the financial statement items to

21

which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.

We have no off-balance sheet arrangements.

We have not paid any dividends, and do not expect to pay any dividends in the future.

The critical accounting policies used in the preparation of our audited consolidated financial statements are discussed in our Form 10-K. There were no changes to these policies during the three months ended September 30, 2022.

Management’s Discussion of Financial Condition

Liquidity and Capital Resources

Liquidity

We had working capital of $13.0 million and $9.1 million as of September 30, 2022 and December 31, 2021, respectively.

On October 6, 2020, we completed a public offering (the “2020 Public Offering”) of 5,462,500 shares of our common stock, at a public offering price of $1.75 per share, which included a full exercise of the underwriters’ option to purchase 712,500 additional shares of common stock from us. We received approximately $8.7 million of net proceeds, after deducting underwriting discounts and commissions, but before offering expenses. During 2021 and the nine months ended September 30, 2022, we deployed proceeds to fund the ALT acquisition, as well as various principal transactions in both our Financial Assets and Industrial Assets Divisions.

Our current assets as of September 30, 2022 increased to $26.5 million compared to $23.3 million as of December 31, 2021 primarily due to an increase in cash as a result of cash provided by operating activities during the nine months ended September 30, 2022. Our current liabilities were $13.5 million as of September 30, 2022 and $14.2 million at December 31, 2021. Changes for the nine months ended September 30, 2022 consisted of a decrease in payables to sellers of $0.6 million and a decrease in the current portion of third party debt of $1.9 million offset by an increase in accounts payable of $1.5 million and current portion of lease liabilities of $0.2 million.

During the nine months ended September 30, 2022, our primary source of cash was the cash on hand plus the cash provided by our asset liquidation business. Cash disbursements during the nine months ended September 30, 2022 consisted primarily of investments in equity method investments of $8.1 million, repayment on our 2021 Credit Facility of $1.9 million, repayment on our ALT Note of $0.4 million, payment of operating expenses, and settlement of auction liabilities.

We believe we can fund our operations and our debt service obligations for at least 12 months from the date of filing this quarterly report through a combination of cash flows from our on-going asset liquidation operations, proceeds from the 2020 Public Offering, and draws on our 2021 Credit Facility, as needed.

Our indebtedness consists of a promissory note dated August 23, 2021 (the “ALT Note”) issued in the amount of $2.0 million as part of the aggregate purchase price paid to acquire certain assets and liabilities of American Laboratory Trading, as well as any amounts borrowed under our Credit Facility. We are required to pay off the ALT Note in 48 equal installments of approximately $44,000 with an interest rate of 3% per annum and a maturity date of August 23, 2025. On May 5, 2021, we entered into a secured promissory note, business loan agreement, commercial security agreement and agreement to provide insurance (the “Credit Facility”) with C3bank, for a $10.0 million revolving line of credit. The Credit Facility matures on May 7, 2023 and replaces our previous credit facility with C3bank of $5.0 million, which matured on April 5, 2021. We are permitted to use the proceeds of the loan solely for our business operations. As of September 30, 2022, we had no outstanding balance on the Credit Facility.

Ownership Structure and Capital Resources

•
As of September 30, 2022, the Company had stockholders’ equity of $38.3 million, as compared to $32.6 million as of December 31, 2021.
•
On May 5, 2021, the Company entered into the 2021 Credit Facility. The 2021 Credit Facility has a maturity date of May 7, 2023. As of September 30, 2022, we had no outstanding balance on the Credit Facility.
•
We determine our future capital and operating requirements based upon our current and projected operating performance and the extent of our contractual commitments. We expect to be able to finance our future operations through cash flows

22

from our asset liquidation business, proceeds from the 2020 Public Offering, and draws on the 2021 Credit Facility, as needed. Capital requirements are generally limited to repayment of our debt obligations, investments in notes receivables, purchases of surplus and distressed assets and payment on lease obligations. We believe that our current capital resources are sufficient for these requirements. In the event additional capital is needed, we will draw on the 2021 Credit Facility.

Cash Position and Cash Flows

Cash and cash equivalents as of September 30, 2022 were $17.5 million as compared to $13.6 million as of December 31, 2021, an increase of approximately $3.9 million.

Cash provided by (used in) operating activities. Cash provided by operations was $2.6 million during the nine months ended September 30, 2022 as compared to cash used in operating activities of $4.1 million during the same period in 2021. The approximate $6.7 million change was primarily attributable to a change of $7.3 million in operating assets and liabilities during the nine months ended September 30, 2022 as compared to the same period in 2021. The amount was further attributable to a change in net income adjusted for noncash items, which was $0.6 million lower during the nine months ended September 30, 2022 as compared to the same period in 2021.

The significant changes in operating assets and liabilities during the nine months ended September 30, 2022 as compared to the same period in 2021 are primarily due to the nature of our operations. We earn revenue from discrete asset liquidation deals that vary considerably with respect to their magnitude and timing, and that can consist of fees, commissions, asset sale proceeds, or a combination thereof. The operating assets and liabilities associated with these deals are, therefore, subject to the same variability and can be quite different at the end of any given period.

Cash provided by (used in) investing activities. Cash provided by investing activities during the nine months ended September 30, 2022 was $3.9 million compared to cash used in investing activities of $7.3 million during the same period in 2021.

Cash provided by investing activities during the nine months ended September 30, 2022 consisted primarily of payments received on notes receivable of $2.4 million as well as return of investment and cash distributions received from equity method investments of $10.2 million in the aggregate, which included $1.7 million related to specialty lending activity within our Financial Assets Division, $5.9 million from the sale of the remaining real estate assets of CPFH LLC, the joint venture, located in Huntsville, Alabama, and $2.6 million from the sales of real estate and machinery and equipment assets of KNFH LLC.

Cash provided by investing activities during the nine months ended September 30, 2022 was offset by cash used in investment in equity method investments of $8.1 million, of which $6.6 million related to specialty lending activity within our Financial Assets Division and $1.5 million cash used in our Industrial Assets Division directly related to the acquisition of two pharmaceutical plants, formerly of Nesher Pharmaceuticals.

Cash used in investing activities during the nine months ended September 30, 2021 of $7.3 million was primarily attributable to the acquisition of certain assets and liabilities of American Laboratory Trading for $4.3 million and the acquisition of real estate used in American Laboratory Trading’s business for $1.3 million, investment in notes receivable of $5.9 million and investment in equity method investments of $1.1 million, offset by payments received on notes receivables of $3.4 million and cash received on transfer of notes receivable to partners of $2.0 million.

Cash (used in) provided by financing activities. Cash used in financing activities was approximately $2.6 million during the nine months ended September 30, 2022 as compared to cash provided by financing activities of $1.2 million for the same period ended September 30, 2021. Financing activities during the nine months ended September 30, 2022 consisted primarily of a $1.9 million repayment to our 2021 Credit Facility, $0.4 million in repayments to our ALT Note and $0.3 million repurchase of our common stock.

Cash provided by financing activities during the nine months ended September 30, 2021 consisted primarily of $2.0 million in proceeds from the issuance of the ALT Note as part of the acquisition of certain assets and liabilities of American Laboratory Trading offset by payments of tax withholdings related to cashless exercises of stock option awards, in excess of proceeds from issuance of common stock related to standard exercises of stock option awards.

Contractual Obligations

Our significant contractual obligations are our third party loans, client and partner asset liquidation settlement payments and lease obligations. The loan and lease obligations are fully described in the notes to the condensed consolidated financial statements included in our Form 10-K.

23

On August 23, 2021, a wholly-owned subsidiary (“ALT Purchaser”) of HGI acquired (the “Transaction”) certain assets and liabilities of American Laboratory Trading, pursuant to the terms and conditions of an Asset Purchase Agreement (the “Asset Purchase Agreement”), dated August 18, 2021, among the Company, American Laboratory Trading and certain individuals named therein. The aggregate purchase price paid to American Laboratory Trading was approximately $4.3 million, consisting of $2.3 million in cash and a $2.0 million subordinated promissory note with an interest rate of 3% per annum and a maturity date of August 23, 2025 (the “ALT Note”). The Asset Purchase Agreement contains customary representations and warranties and covenants by each party. American Laboratory Trading and ALT Purchaser are obligated, subject to certain limitations, to indemnify the other under the Asset Purchase Agreement for losses arising from certain breaches of the Asset Purchase Agreement and for certain other liabilities, subject to applicable limitations set forth in the Asset Purchase Agreement. HGI has guaranteed the obligations of ALT Purchaser under the terms of the Asset Purchase Agreement and the ALT Note.

Management’s Discussion of Results of Operations

The following table sets out the Company’s condensed consolidated results of operations for the three and nine months ended September 30, 2022 and 2021 (dollars in thousands).

|  | Three Months Ended September 30, |  |  | Change |  |  | Nine Months Ended September 30, |  |  | Change |
|  | 2022 |  |  | 2021 |  |  | Dollars |  |  | Percent |  |  | 2022 |  |  | 2021 |  |  | Dollars |  |  | Percent |
Revenues: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Services revenue |  | $ | 7,349 |  |  | $ | 4,822 |  |  | $ | 2,527 |  |  |  | 52 | % |  | $ | 16,112 |  |  | $ | 14,020 |  |  | $ | 2,092 |  |  |  | 15 | %
Asset sales |  |  | 5,312 |  |  |  | 1,169 |  |  |  | 4,143 |  |  |  | 354 | % |  |  | 16,971 |  |  |  | 4,248 |  |  |  | 12,723 |  |  |  | 300 | %
Total revenues |  |  | 12,661 |  |  |  | 5,991 |  |  |  | 6,670 |  |  |  | 111 | % |  |  | 33,083 |  |  |  | 18,268 |  |  |  | 14,815 |  |  |  | 81 | %
Operating costs and expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of services revenue |  |  | 2,051 |  |  |  | 1,100 |  |  |  | 951 |  |  |  | 86 | % |  |  | 3,715 |  |  |  | 3,235 |  |  |  | 480 |  |  |  | 15 | %
Cost of asset sales |  |  | 3,015 |  |  |  | 675 |  |  |  | 2,340 |  |  |  | 347 | % |  |  | 12,048 |  |  |  | 1,870 |  |  |  | 10,178 |  |  |  | 544 | %
Selling, general and administrative |  |  | 5,693 |  |  |  | 3,494 |  |  |  | 2,199 |  |  |  | 63 | % |  |  | 14,907 |  |  |  | 11,134 |  |  |  | 3,773 |  |  |  | 34 | %
Depreciation and amortization |  |  | 134 |  |  |  | 105 |  |  |  | 29 |  |  |  | 28 | % |  |  | 400 |  |  |  | 294 |  |  |  | 106 |  |  |  | 36 | %
Total operating costs and expenses |  |  | 10,893 |  |  |  | 5,374 |  |  |  | 5,519 |  |  |  | 103 | % |  |  | 31,070 |  |  |  | 16,533 |  |  |  | 14,537 |  |  |  | 88 | %
Earnings of equity method investments |  |  | 1,706 |  |  |  | (84 | ) |  |  | 1,790 |  |  |  | 2131 | % |  |  | 5,960 |  |  |  | (83 | ) |  |  | 6,043 |  |  |  | 7281 | %
Operating income |  |  | 3,474 |  |  |  | 533 |  |  |  | 2,941 |  |  |  | 552 | % |  |  | 7,973 |  |  |  | 1,652 |  |  |  | 6,321 |  |  |  | 383 | %
Interest and other expense, net |  |  | (21 | ) |  |  | (6 | ) |  |  | (15 | ) |  |  | 250 | % |  |  | (96 | ) |  |  | 6 |  |  |  | (102 | ) |  |  | 1700 | %
Income before income tax expense (benefit) |  |  | 3,453 |  |  |  | 527 |  |  |  | 2,926 |  |  |  | 555 | % |  |  | 7,877 |  |  |  | 1,658 |  |  |  | 6,219 |  |  |  | 375 | %
Income tax expense (benefit) |  |  | 1,153 |  |  |  | 53 |  |  |  | 1,100 |  |  |  | 2075 | % |  |  | 2,354 |  |  |  | (435 | ) |  |  | 2,789 |  |  |  | 641 | %
Net income |  | $ | 2,300 |  |  | $ | 474 |  |  | $ | 1,826 |  |  |  | 385 | % |  | $ | 5,523 |  |  | $ | 2,093 |  |  | $ | 3,430 |  |  |  | 164 | %

Our asset liquidation business model has several components: (1) traditional fee-based asset disposition services, such as commissions from on-line and webcast auctions, liquidations and negotiated sales, and commissions from the NLEX charged-off receivables business, (2) the acquisition and subsequent disposition of distressed and surplus assets, including industrial machinery and equipment and real estate, and (3) fees earned for appraisal, management advisory services and specialty finance services.

We report segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of our reportable segments. We manage our business primarily on differentiated revenue streams for services offered. Our reportable segments consist of the Industrial Asset Division and Financial Assets Division. Our Industrial Assets Division advises enterprise and financial customers on the sale of industrial assets mostly from surplus and sometimes distressed circumstances while acting as an agent, guarantor or principal in the sale. Our Financial Assets Division provides liquidity to issuers of consumer credit that are looking to monetize nonperforming and charged-off loans — loans that creditors have written off as uncollectable. Nonperforming and charged-off loans typically originate from banks that issue unsecured consumer credit.

We evaluate the performance of reportable segments based primarily on net operating income. Further, we do not utilize segmented asset information to evaluate the performance of reportable segments and we do not include intercompany transfers between segments for management reporting purposes.

24

The following table sets forth certain financial information for the Company's reportable segments (in thousands):

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Industrial Assets Division: |  |  |  |  |  |  |  |  |  |  |  |
Net operating income |  | $ | 3,058 |  |  | $ | 765 |  |  | $ | 7,247 |  |  | $ | 2,538 |
Financial Assets Division: |  |  |  |  |  |  |  |  |  |  |  |
Net operating income |  | $ | 1,566 |  |  | $ | 449 |  |  | $ | 3,480 |  |  | $ | 1,372 |
Corporate and Other: |  |  |  |  |  |  |  |  |  |  |  |
Net operating loss |  | $ | (1,150 | ) |  | $ | (681 | ) |  | $ | (2,754 | ) |  | $ | (2,258 | )
Consolidated: |  |  |  |  |  |  |  |  |  |  |  |
Net operating income |  | $ | 3,474 |  |  | $ | 533 |  |  | $ | 7,973 |  |  | $ | 1,652 |

Three-Month Period Ended September 30, 2022 Compared to Three-Month Period Ended September 30, 2021

Revenues and cost of revenues – Revenues were $12.7 million during the three months ended September 30, 2022 compared to $6.0 million during the same period in 2021. Costs of services revenue and asset sales were $5.1 million during the three months ended September 30, 2022 compared to $1.8 million during the same period in 2021. The gross profit of these items was $7.6 million during the three months ended September 30, 2022 compared to $4.2 million during the same period in 2021, an increase of approximately $3.4 million, or approximately 80%. The increased gross profit in the third quarter of 2022 reflects the vagaries of the timing and magnitude of asset liquidation transactions.

Selling, general and administrative expense – Selling, general and administrative expense was $5.7 million during the three months ended September 30, 2022 compared to $3.5 million during the same period in 2021.

Significant components of selling, general and administrative expense for the three months ended September 30, 2022 and September 30, 2021 are shown below (dollars in thousands):

|  | Three Months Ended September 30, |  |  |  |
|  | 2022 |  |  | 2021 |  |  | % change |
Compensation |  |  |  |  |  |  |  |  |
HGP |  | $ | 1,765 |  |  | $ | 1,141 |  |  |  | 55 | %
ALT |  |  | 389 |  |  |  | 118 |  |  |  | 230 | %
NLEX |  |  | 1,255 |  |  |  | 764 |  |  |  | 64 | %
HGI |  |  | 664 |  |  |  | 228 |  |  |  | 191 | %
HGC |  |  | 138 |  |  |  | 94 |  |  |  | 47 | %
Stock-based compensation |  |  | 170 |  |  |  | 102 |  |  |  | 67 | %
Consulting |  |  | 32 |  |  |  | 13 |  |  |  | 146 | %
Board of Directors fees |  |  | 89 |  |  |  | 62 |  |  |  | 44 | %
Accounting, tax and legal professional fees |  |  | 296 |  |  |  | 293 |  |  |  | 1 | %
Insurance |  |  | 119 |  |  |  | 112 |  |  |  | 6 | %
Occupancy |  |  | 291 |  |  |  | 241 |  |  |  | 21 | %
Travel and entertainment |  |  | 156 |  |  |  | 121 |  |  |  | 29 | %
Advertising and promotion |  |  | 89 |  |  |  | 66 |  |  |  | 35 | %
Information technology support |  |  | 103 |  |  |  | 86 |  |  |  | 20 | %
Other |  |  | 137 |  |  |  | 53 |  |  |  | 158 | %
Total selling, general & administrative expense |  | $ | 5,693 |  |  | $ | 3,494 |  |  |  | 63 | %

As compared to the third quarter of 2021, there was an increase in selling, general and administrative expense during the third quarter of 2022 primarily due to increased compensation and operation expenses related to the acquisition of ALT in the third quarter

25

of 2021 and increased compensation as a result of our improved financial performances in our other divisions. The increased travel and entertainment expenses were due to the lift in travel restrictions related to the COVID-19 pandemic.

Depreciation and amortization expense – Depreciation and amortization expense was $0.1 million during the three months ended September 30, 2022 and the same period in 2021, which consisted primarily of amortization expense related to intangible assets.

Nine-Month Period Ended September 30, 2022 Compared to Nine-Month Period Ended September 30, 2021

Revenues and cost of revenues – Revenues were $33.1 million during the nine months ended September 30, 2022 compared to $18.3 million during the same period in 2021. Costs of services revenue and asset sales were $15.8 million during the nine months ended September 30, 2022 compared to $5.1 million during the same period in 2021. The gross profit of these items was $17.3 million during the nine months ended September 30, 2022 compared to $13.2 million during the same period in 2021, an increase of approximately $4.2 million, or approximately 32%. The increased gross profit in the current year reflects the vagaries of the timing and magnitude of asset liquidation transactions.

Selling, general and administrative expense – Selling, general and administrative expense was $14.9 million during the nine months ended September 30, 2022 and $11.1 million during the same period in 2021.

Significant components of selling, general and administrative expense for the nine months ended September 30, 2022 and September 30, 2021 are shown below (dollars in thousands):

|  | Nine Months Ended September 30, |  |  |  |
|  | 2022 |  |  | 2021 |  |  | % change |
Compensation |  |  |  |  |  |  |  |  |
HGP |  | $ | 4,618 |  |  | $ | 4,039 |  |  |  | 14 | %
ALT |  |  | 1,154 |  |  |  | 118 |  |  |  | 878 | %
NLEX |  |  | 3,129 |  |  |  | 2,519 |  |  |  | 24 | %
HGI |  |  | 1,405 |  |  |  | 783 |  |  |  | 79 | %
HGC |  |  | 425 |  |  |  | 328 |  |  |  | 30 | %
Stock-based compensation |  |  | 384 |  |  |  | 313 |  |  |  | 23 | %
Consulting |  |  | 72 |  |  |  | 37 |  |  |  | 95 | %
Board of Directors fees |  |  | 235 |  |  |  | 187 |  |  |  | 26 | %
Accounting, tax and legal professional fees |  |  | 895 |  |  |  | 930 |  |  |  | (4 | )%
Insurance |  |  | 342 |  |  |  | 292 |  |  |  | 17 | %
Occupancy |  |  | 797 |  |  |  | 725 |  |  |  | 10 | %
Travel and entertainment |  |  | 521 |  |  |  | 241 |  |  |  | 116 | %
Advertising and promotion |  |  | 310 |  |  |  | 239 |  |  |  | 30 | %
Information technology support |  |  | 290 |  |  |  | 241 |  |  |  | 20 | %
Other |  |  | 330 |  |  |  | 142 |  |  |  | 132 | %
Total selling, general & administrative expense |  | $ | 14,907 |  |  | $ | 11,134 |  |  |  | 34 | %

As compared to the nine months ended September 30, 2021, there was an increase in selling, general and administrative expense during the nine months ended September 30, 2022 primarily due to increased compensation and operation expenses related to the acquisition of ALT in the third quarter of 2021 and increased compensation expense as a result of our improved financial performances in our other divisions. The increased travel and entertainment expenses were due to the lift in travel restrictions related to the COVID-19 pandemic.

Depreciation and amortization expense – Depreciation and amortization expense was $0.4 million during the nine months ended September 30, 2022 and $0.3 million during the same period in 2021, which consisted primarily of amortization expense related to intangible assets.

26

Key Performance Indicators

We monitor a number of financial and non-financial measures on a regular basis in order to track our underlying operational performance and trends. Other than the operating income of our liquidation business (a GAAP financial measure as shown in our Condensed Consolidated Income Statements), which we believe is the most important measure of our operational performance and trends, we believe that EBITDA and Adjusted EBITDA (non-GAAP financial measures) are key performance indicators (KPIs) for our business. These KPIs may not be defined or calculated in the same way as similar KPIs used by other companies.

We prepared our unaudited condensed consolidated financial statements in accordance with GAAP. We define EBITDA as net income plus depreciation and amortization, interest and other expense, and provision for income taxes. Adjusted EBITDA reflects EBITDA adjusted further to eliminate the effects of stock-based compensation. Management uses EBITDA and Adjusted EBITDA in assessing the Company’s results, evaluating the Company’s performance and in reaching operating and strategic decisions. Management believes that the presentation of EBITDA and Adjusted EBITDA, when considered together with our GAAP financial statements and the reconciliation to the most directly comparable GAAP financial measure, is useful in providing investors a more complete understanding of the factors and trends affecting the underlying performance of the Company on a historical and ongoing basis. Our use of EBITDA and Adjusted EBITDA is not meant to be, and should not be, considered in isolation or as a substitute for, or superior to, any GAAP financial measure. You should carefully evaluate the financial information below, which reconciles our GAAP reported net income to EBITDA and Adjusted EBITDA for the periods presented (in thousands).

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Net income |  | $ | 2,300 |  |  | $ | 474 |  |  | $ | 5,523 |  |  | $ | 2,093 |
Add back: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 134 |  |  |  | 105 |  |  |  | 400 |  |  |  | 294 |
Interest and other expense, net |  |  | 21 |  |  |  | 6 |  |  |  | 96 |  |  |  | (6 | )
Income tax expense |  |  | 1,153 |  |  |  | 53 |  |  |  | 2,354 |  |  |  | (435 | )
EBITDA |  |  | 3,608 |  |  |  | 638 |  |  |  | 8,373 |  |  |  | 1,946 |
Management add back: |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  | 170 |  |  |  | 102 |  |  |  | 384 |  |  |  | 313 |
Separation Agreement |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 200 |
Adjusted EBITDA |  | $ | 3,778 |  |  | $ | 740 |  |  | $ | 8,757 |  |  | $ | 2,459 |

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

As a Smaller Reporting Company, we are not required to provide the information required by this item.

Item 4. Controls and Procedures.

As of the end of the period covered by this quarterly report, our Chief Executive Officer and Chief Financial Officer (the “Certifying Officers”) conducted evaluations of our disclosure controls and procedures. As defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the term “disclosure controls and procedures” means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the Certifying Officers, to allow timely decisions regarding required disclosure. Based on this evaluation, the Certifying Officers have concluded that our disclosure controls and procedures were effective.

Further, there were no changes in our internal control over financial reporting during the three months ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

27

PART II – OTHE R INFORMATION

Item 1. Legal Proceedings

There have been no material changes to the legal proceedings discussed in our Form 10-K.

Item 1A. R isk Factors

As a Smaller Reporting Company, we are not required to provide the information required by this item.

Item 2. Unregistered Sales of Equi ty Securities and Use of Proceeds.

Purchases of Equity Securities

During the three months ended September 30, 2022, repurchases of the Company's common stock were as follows:

Period |  | (a) Total Number of Shares Purchased [1] |  |  | (b) Average Price Paid per Share [2] |  |  | (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  |  | (d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs [3] |
July 1 through July 31, 2022 |  |  | 4,502 |  |  | $ | 1.50 |  |  |  | 76,014 |  |  | $ | 3,888,831 |
August 1 through August 31, 2022 |  |  | 62,994 |  |  | $ | 1.72 |  |  |  | 139,008 |  |  | $ | 3,780,431 |
September 1 through September 30, 2022 |  |  | 44,691 |  |  | $ | 1.70 |  |  |  | 183,699 |  |  | $ | 3,705,560 |
[1] No shares of our common stock were purchased other than through a publicly announced plan or program. |
[2] Amounts in this column reflect weighted average price paid per share, which includes commissions and other expenses associated with the repurchases. |
[3] This column reflects the approximate dollar value of shares of our common stock that are available for purchase under the $4.0 million repurchase program authorized by our Board of Directors on May 5, 2022 (“2022 Repurchase Program”). The 2022 Repurchase Program expires in June 2025. |

Item 3. Defaults Upo n Senior Securities.

None.

Item 4. Mine Saf ety Disclosures.

Not applicable.

28

Item 5. Other Information.

None.

Item 6. Exhibits.

(a) Exhibits

Exhibit No. |  | Identification of Exhibit
3.1 |  | Amended and Restated Articles of Incorporation (restated for filing purposes only) (filed as Exhibit 3.1 to the Company’s Annual Report on Form 10-K filed on March 9, 2020 (File No. 000-17973), and incorporated herein by reference).
3.2 |  | Restated Bylaws, as amended (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on September 30, 2020 (File No. 001-39471), and incorporated herein by reference).
4.1 |  | Warrant Agreement by and between Heritage Global Inc. and Napier Park Industrial Asset Acquisition, LP, effective as of March 19, 2019 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on March 25, 2019 (File No. 000-17973), and incorporated herein by reference).
10.1 |  | Loan Modification Agreement and Reaffirmation of Loan, by and between Heritage Global Inc. and C3bank, National Association, effective as of April 1, 2022.
31.1 |  | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) as adopted under Section 302 of the Sarbanes-Oxley Act of 2002
31.2 |  | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) as adopted under Section 302 of the Sarbanes-Oxley Act of 2002
32.1 |  | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 |  | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS |  | Inline XBRL Instance Document
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB |  | Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Non-material schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the SEC.

29

SIGNAT URES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.

|  | Heritage Global Inc.
Date: November 10, 2022 |  | By: |  | /s/ Ross Dove
|  |  |  | Ross Dove
|  |  |  | Chief Executive Officer
|  |  |  | (Principal Executive Officer)
|  | By: |  | /s/ Brian J. Cobb
|  |  |  | Brian J. Cobb
|  |  |  | Chief Financial Officer
|  |  |  | (Principal Financial Officer and Principal Accounting Officer)

30